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The ammo terminal sequence of the myosin light cham (Mr = 20 000) Isolated from chicken gizzards was 
found to be acetyl-Ser-Ser-Lys-Ag-Ala-Lys-Ala-Lys-Thr-Thr-Lys-Lys-Arg-Pro-Gln-Arg-Ala-Thr-Ser(P)- 
Asn-Val-Phe. This sequence assignment differs from that reported by Msuta et al. [(1981) European J. 
Biochem. 117, 4171 in the order of the tryptic peptides. The revised amino acid sequence exhibits greater 
homology with the phosphorylation site sequences of the regulatory light chains from cardiac and skeletal 
muscle. Moreover it is now apparent why synthetic peptides corresponding to the previously reported 
sequence were very poor substrates for the myosin light chain kinase. 
Protein kmase Myosin Specrficity 
1. INTRODUCTION 
The phosphorylation of the myosin regulatory 
light chains (Mr 20000) is believed to initiate con- 
traction in vertebrate smooth muscles (review [l]). 
The enzyme responsible for catalyzing this reac- 
tion, Ca’+-calmodulin-dependent myosin light 
chain kinase, has been purified to homogeneity 
and characterized [2]. This kinase phosphorylates 
a single serine residue near the amino-terminus of 
the light chain [3] which has been shown to be 
Ser-19 in the complete amino acid sequence of the 
chicken gizzard myosin regulatory light chain 
determined in [4]. Sequence studies on the amino- 
terminal region around the phosphorylation site of 
this light chain (Jakes and Kendrick-Jones, un- 
published) however, indicated a different sequence 
from that in [4]. Furthermore, synthetic peptides 
of this region corresponding to the published se- 
quence [4] were relatively poor substrates for 
myosin light chain kinase [5] whereas synthetic 
peptides corresponding to the alternative sequence 
(unpublished) were phosphorylated with apparent 
K,,, values comparable to those of the intact light 
chain [5]. Since the correct amino acid sequence is 
vital for the design of synthetic peptide substrates 
and specific antigenic sites, we have re-examined 
the amino acid sequence on the amino-terminal 
side of the phosphorylatable serine in myosin light 
chains from chicken gizzards. 
2. MATERIALS AND METHODS 
Chicken gizzard myosin light chains [3,6], 
myosin light chain kinase [2,7] and CAMP- 
dependent protein kinase [8] were purified as 
described. Trypsin (treated with tosylphenylchlo- 
romethyl ketone) and chymotrypsin were from 
Boehringer. Automated sequence analysis was car- 
ried out using an Applied Biosystems gas phase 
sequenator [9] or manually using the Dansyl- 
Edman procedure [lo]. 
3. RESULTS 
3.1. Isolation of peptic phosphopeptide 
The gizzard myosin regulatory light chain was 
phosphorylated stoichiometrically with myosin 
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light chain kinase [7]. The reaction was stopped by 
adding trichloroacetic acid to 15% (w/v) and the 
precipitated light chains were isolated by cen- 
trifugation and oxidized with performic acid [ 111. 
The oxidized phosphorylated myosin light chains 
were lyophilized, resuspended in 5% HCOOH 
(v/v) and digested with pepsin (92Fg/ml at 37°C 
for 4 h) then chromatographed on SP-Sephadex 
(fig.lA) with a pyridine-acetic acid gradient. The 
major “P radioactive peak accounted for 81% of 
the 32P radioactivity applied to the SP-Sephadex 
column. The peptic phosphorylated peptide was 
further purified by reverse-phase HPLC on an 
RP-300 Aquapore column (Brownlee Labs) with a 
linear gradient of 12-24070 CH&N in 0.1% 
CF3COOH (v/v) over 30 min. The single 32P 
radioactive peak was recovered with 61% yield. 
The amino acid composition of the peptic 
phosphopeptide (table 1) was in agreement with 
that expected from the sequence in [4]. Since the 
amino-terminus of the myosin light chain is 
blocked [4] no attempt was made to sequence the 
peptic phosphopeptide directly. 
3.2. Isolation of tryptic phosphopeptides 
The peptic phosphopeptide was succinylated 
(135-fold excess of succinic anhydride) and further 
purified by reverse-phase HPLC as described 
above except with a steeper gradient of CHJCN 
(see fig.lB). The succinylated phosphopeptide was 
digested with trypsin [75 pg/ml in 0.1 M 
N&HCOs (pH 7.8) at 37°C for 2 h]. The resultant 
tryptic peptides were purified by reverse-phase 
HPLC as described for the succinylated 
phosphopeptide. Three major tryptic peptides 
were obtained (fig.lC). Only the third peptide, 
TsP3, was associated with “P radioactivity. The 
amino acid composition of these peptides is given 
in table 1. Peptide TsPr had the composition Ser2, 
Lys, Arg expected of the amino terminal tryptic 
peptide [4] (see below). Peptides TsPz and TsP3 
were subject to automated sequence analysis. The 
sequences were found to be: TsPz, Ala-Lys*-Ala- 
Lys*-Thr-Thr-Lys*-Lys*-Arg-Pro-Gln-Arg and 
TsP3, Ala-Lys*-Ala-Lys*-Thr-Thr-Lys*-Lys*- 
Arg-Pro-Gln-Arg-Ala-(Thr Ser Asn Val Phe). 
The same sequences were obtained on tryptic 
peptides derived from two independent isolations 
of the peptic phosphopeptide from the myosin 
light chains. PTH-lysine residues were not 
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Fig. 1. Peptrde purification. (A) SP-Sephadex ron- 
exchange chromatography following peptic digestion of 
phosphorylated gizzard myosin light chains. 
Phosphorylated peptide was eluted with a linear gradient 
of 0.05-2.0 M pyridme in acetic acid. Fractions (7.5 ml) 
were collected and an aliquot (20~1) subjected to liquid 
scintillation counting. The major 32P radioactive peak 
was collected. (B) Purified phosphorylated peptic 
peptide was treated with succimc anhydride and the 
succinylated phosphopeptide purified by reverse-phase 
HPLC on an RP-300 column (Brownlee Labs). Peptides 
were eluted with a linear gradient of O-24% CH&N m 
0.1% CFsCOOH (v/v) over 30 min at a flow rate of 
1.0 ml/min and detected by monitoring absorbance at 
210 nm. The major absorbance peak was collected. (C) 
The purified succinylated phosphopeptrde was digested 
with trypsin (see text) and the digest chromatographed 
on an RP-300 reverse-phase HPLC column (Brownlee 
Labs). Peptides were eluted as in B and major 
absorbance peaks collected. 
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Table 1 3.4. Tryptic peptides of succinylated light chain 
Amino acid analysis of phosphopeptides from myosin 
light chain 
Ammo 
acid 
P TsPl TsPz TsP3 
Asp/Asn 1.10 (1) 1.29 (1) 
Thr 2.47 (3) 2.26 (2) 2.58 (3) 
Ser 2.89 (3) 2.03 (2) 0.74 (1) 
Glu/Gln 1.05 (1) 1.11 (1) 1.41 (1) 
Pro 0.95 (1) 1.11 (1) 1.04 (1) 
Ala 3.03 (3) 2.08 (2) 3.26 (3) 
Val 0.93 (1) 2.21 (1) 
Phe 0.74 (1) 0.74 (1) 
LYS 5.20 (5) 0.91 (1) 3.49 (4) 2.64 (4) 
Ar8 3.12 (3) 1.05 (1) 1.95 (2) 2.09 (2) 
Serine and threonine were corrected for 10 and 5% 
destruction, respectively. Hydrolyses were for 24 h in 
5.6 M HCl at 110°C. The figures in parentheses are 
expected values based on the sequence r ported here. P, 
peptide phosphopeptide. TsPl, TsPz and TsPs are the 3 
tryptic peptides isolated following tryptic digestion of 
the succinylated peptic phosphopeptide 
positively identified since the lysine was suc- 
cinylated. Blanks were obtained after Edman 
degradation at 4 steps corresponding to the 4 lysine 
residues expected from the amino acid composi- 
tion. The carboxyl terminal pentapeptide of TsP3 
was lost from the sequencer on both occasions. 
From the tryptic digestion results we would have 
expected a fourth tryptic peptide, Ala-Thr-Ser- 
Asn-Val-Phe, however, this peptide was not 
recovered from HPLC chromatography of the 
tryptic digest (fig. IC). 
Myosin light chain (Mr 20000) was succinylated 
(lOO-fold excess of succinic anhydride) in 6 M 
guanidine hydrochlortde at pH 9.0. The suc- 
cinylated protein was digested with trypsin (100 : 1, 
w/w) and the tryptic peptides isolated by reverse- 
phase HPLC (uBondapak C18 column, Waters 
Associates) in 10 mM ammonium acetate buffer 
(pH 4.5) and a gradient of O-60% CH3CN over 
45 min. The resolved peptides were freeze-dried, 
redissolved in Hz0 (100 ~1) and aliquots analysed 
for amino acid content and dansyl amino-terminal 
acid identification. One of the peptides obtained 
(peak 6, not shown) had the composition Serz, Lys, 
Arg and when subjected to mass spectrometry [IO] 
revealed the primary sequence acetyl-Ser-Ser-Lys. 
This peptide is the amino-terminus of the myosin 
light chain and is the same as peptide TsPi (table 
1). Another peptide (peak 8, not shown) had the 
composition Thrz, Glx, Pro, Alaz, Lys4, Argz and 
following subtractive Edman degradation revealed 
the sequence Ala-Lys-Ala-Lys-Thr-Thr-Lys-Lys- 
Arg-Pro-Glx. The sequence of this peptide cor- 
responds with that of the tryptic peptide TsP2 
(table 1) obtained by automatic sequencing of the 
peptic phosphopeptide following succinylation and 
tryptic digestion (see section 3.2). 
4. DISCUSSION 
3.3. Chymotryptic digestion of phosphorylated 
light chain 
Chymotryptic digestion of the phosphorylated 
light chains [3] yielded 3 32P-labelled peptides on 
two-dimensional chromatography and electropho- 
resis as in [3]. The sequences of two of these pep- 
tides were obtained by subtractive Edman degrada- 
tion. The first, Arg-Ala-Thr-Ser(P)-Asn-Val-Phe 
was reported in [3], the second being Lys-Arg-Pro- 
Glx-Arg-Ala-Thr-Ser(P)-Asn-Val-Phe. The se- 
quence of the chymotryptic phosphopeptides 
agrees with that obtained with the tryptic peptides 
(see above). 
The amino-terminal sequence of the myosin 
light chain (Mr 20000) isolated from chicken giz- 
zards was found to be acetyl-Ser-Ser-Lys-Arg-Ala- 
Lys-Ala-Lys-Thr-Thr-Lys-Lys-Arg-Pro-Gln-Arg- 
Ala-Thr-Ser-Asn-Val-Phe. This sequence assign- 
ment gives rise to precisely the same amino acid 
composition as the sequence in [4] but differs in 
the order of the tryptic peptides. Our sequence was 
determined from both tryptic and chymotryptic 
peptides derived from phosphorylated myosin light 
chains and was also supported by the sequence 
analysis of tryptic peptides derived from non- 
phosphorylated, succinylated myosin light chains. 
The sequence reported herein is consistent with 
the phosphorylation pattern and substrate 
specificity properties of both myosin light chain 
kinase and CAMP-dependent protein kinase. We 
[5] have shown that the synthetic peptide cor- 
responding to this sequence is a much better 
substrate for myosin light chain kinase (table 2) 
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Table 2 
Kinetics of peptide phosphorylation’ 
Peptrde sequence CAMP-dependent 
protein kinase 
Km V max 
(/IM) ~mol~mm-l~mg-l) 
KAKTTKKRPQRATSJVFS NHzb 120 0.29 
RPQRAKAKTTKATPVFS NHzC 165 0.016 
* From [15] 
b Peptrde analog of sequence reported here with serine at residue 23 
’ Peptide analog of sequence reported in [4] with serme at residue 23 
Myosin light 
chain kinase 
KItI V max 
(uM) bmol - min-’ - mg-‘) 
6.9 3.4 
193 0.39 
than the peptide corresponding to the sequence in 
[4]. Furthermore, it has been shown in [ 131 that 
CAMP-dependent protein kinase phosphorylates 
the gizzard myosin light chain at the same site as 
myosin light chain kinase. The CAMP-dependent 
protein kinase usually requires arginine residues 
within one or two residues of the phosphorylatable 
serine [14]. In our sequence there is an arginine 
within two residues of Ser-19 whereas in the 
published sequence [4] the nearest arginine is 10 
residues away (table 3). The substrate specificity of 
CAMP-dependent protein kinase is further 
demonstrated when the kinetics of phosphoryla- 
tion of the peptides corresponding to both se- 
quences are compared (table 2), i.e., the peptide 
with our sequence is a better substrate for the 
enzyme. 
It is of interest to compare the amino-terminal 
sequence of the smooth muscle light chain with 
those of other regulatory light chains (table 3). One 
of the striking features is a tribasic residue se- 
quence located 4 or 5 residues from the phospho- 
rylated serine in all the vertebrate regulatory light 
chains. This gains further significance since we 
have recently shown that these 3 basic residues are 
essential specificity determinants for smooth mus- 
cle myosin light chain kinase [5]. Whether the 
tribasic residues are also important determinants 
for the cardiac and skeletal muscle enzyme remains 
to be determined. The absence of these residues in 
the molluscan (scallop) regulatory light chain may 
explain our inability to phosphorylate this light 
chain [ 181 and would further exclude the possibili- 
ty that light chain phosphorylation is involved in 
the regulation of contractile activity in molluscs. 
Table 3 
Comparison of the primary structures of the regulatory light chains 
Tissue Sequence Ref. 
Skeletal muscle 16 
Cardiac B 17 
Cardiac A 17 
Gizzard Here 
Gizzard XSSKRKRPQRAKAKTTKATONVFA 4 
Molluscan (scallop) AcADKAASGVLT 19 
Basic residues common to the 4 vertebrate sequences are boxed. The phosphorylatable serine residues are encircled and 
the arginine residue important for the CAMP-dependent protein kinase is marked with an asterisk. The acetylated 
NHz-termini are marked AC 
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